Speak directly to the analyst to clarify any post sales queries you may have.
Senior decision-makers in healthcare are facing a rapidly transforming transcatheter embolization and occlusion device market, shaped by continual technological advancements and evolving care models. Adapting to these changes is critical for sustaining growth, optimizing procurement, and refining clinical and investment strategies.
Market Snapshot: Transcatheter Embolization and Occlusion Device Market
In 2024, the global transcatheter embolization and occlusion device market reached USD 5.94 billion, with expectations to grow to USD 6.73 billion in 2025 and USD 16.03 billion by 2032, reflecting a compound annual growth rate of 13.19%. Growth in this market is driven by increasing reliance on minimally invasive medical procedures and widespread adoption of advanced interventional technology. Healthcare providers worldwide are utilizing these devices across varying clinical applications to improve patient outcomes and streamline operations. The ongoing modernization of healthcare organizations is catalyzing investment realignment and the adoption of next-generation solutions, enabling providers to address shifting standards and expectations within the vascular intervention landscape.
Scope & Segmentation
This report delivers practical segmentation insights, supporting executive teams in making informed decisions related to capital allocation, compliance, procurement planning, and long-term technology investments within the vascular intervention segment.
- Product Types: Embolization coils, liquid embolic agents, microspheres, particulate agents, and vascular plugs are designed for a wide array of vascular interventions, allowing tailored clinical approaches based on procedural needs.
- Material Types: Both biological and synthetic materials are used across patient populations, offering versatility and reinforcing adherence to safety protocols throughout various interventions.
- Technology Platforms: Flow-directed systems, mechanical occlusion devices, and advanced microcatheters expand procedural access, integrating seamlessly into existing workflows and enabling efficient device adoption in diverse clinical environments.
- Applications: Devices are deployed in hemorrhage management, neurovascular and hepatic procedures, peripheral vasculature treatments, and uterine fibroid therapy, providing solutions for both acute and elective clinical scenarios.
- End Users: Hospitals, ambulatory surgery centers, and specialty clinics benefit from the adoption of standardized protocols and an adaptable approach, which helps elevate the quality of care within multifaceted organizational structures.
- Regional Coverage: Comprehensive analysis covers the Americas, Europe, Middle East, Africa, and Asia-Pacific, highlighting the impact of regional regulations, technology adoption rates, and unique care delivery models.
- Company Coverage: In-depth company profiles feature Boston Scientific Corporation, Medtronic plc, Terumo Corporation, and Johnson & Johnson, giving clarity on competitive strategies and their effects on procurement decisions and technology integration within institutions.
Leveraging segmentation enables stakeholders to target high-value segments, drive innovation responsive to market needs, and align investments to evolving standards and regional nuances in healthcare delivery.
Key Takeaways for Senior Decision-Makers
- Minimally invasive treatment options are improving workflow efficiencies and enhancing collaboration among providers, supporting safer procedures throughout the care continuum.
- Ongoing advancements in device engineering are reducing staff training requirements and enabling the widespread use of standardized clinical protocols, leading to faster implementation of new solutions.
- Integrating advanced imaging modalities and artificial intelligence tools is supporting precise resource planning and enabling more tailored patient care.
- As the market develops globally, organizations benefit from constructing operating models that can adapt to rapid changes in care delivery expectations and compliance demands.
- Effective supply chain coordination is increasingly important, as updated regulations and reimbursement frameworks highlight the value of robust partnerships across manufacturing, distribution, and clinical care.
Tariff Impact on the Supply Chain
Recent tariff changes in the United States have disrupted sourcing approaches for essential components, presenting new cost challenges for healthcare systems. Procurement leaders are addressing these shifts by moving toward regionalized production models, diversifying supplier bases, and conducting comprehensive risk assessments to preserve operational resilience and secure reliable device availability.
Methodology & Data Sources
The report’s analysis is built on structured interviews with interventional radiologists and procurement leaders, a thorough literature review, frequent regulatory monitoring, and global trade data analysis. Validation by a multidisciplinary panel ensures that findings and recommendations are credible and actionable for executive management.
Why This Report Matters
- Provides clarity on regulatory and operational complexities, equipping leadership to guide strategic technology decisions.
- Delivers actionable recommendations to mitigate supply chain risks and plan for variability in device requirements across regions and specialties.
- Offers insights on market, regulatory, and technology trends, enabling organizations to sustain operational leadership and adapt effectively to updated standards.
Conclusion
This analysis empowers senior healthcare executives to align their clinical, procurement, and investment decisions, supporting effective adoption of transcatheter embolization and occlusion devices as the healthcare landscape continues to evolve.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Companies Mentioned
The companies profiled in this Transcatheter Embolization & Occlusion Device market report include:- Boston Scientific Corporation
- Medtronic PLC
- Terumo Corporation
- Johnson & Johnson
- Cook Medical LLC
- Merit Medical Systems, Inc.
- Penumbra, Inc.
- AngioDynamics, Inc.
- W. L. Gore & Associates, Inc.
- B. Braun Melsungen AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 185 |
| Published | November 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 6.73 Billion |
| Forecasted Market Value ( USD | $ 16.03 Billion |
| Compound Annual Growth Rate | 13.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


